|
|
|
|
|
|
Did you find this search useful? Yes - No
|
| Viewing 1 - 7 of 7 Full Text results for early_release |
|
|
-
|
Ahmed W, Fan TM, Bostwick JM, Lee TH, Goldman L
cutoff values used to define a positive test (ranging from 50 to 150 μg per liter) and in the timing of blood sampling. Because of the protein's early release and rapid clearance, the diagnostic accuracy of myoglobin levels is highly time dependent. In a prospective study involving 309 patients, de Winter
N Engl J Med 343:584, August 24, 2000 Correspondence
|
-
|
Drazen JM, Campion EW
readers the importance of signing up (at www.nejm.org/alerts) to receive our electronic table of contents and e-mail alerts of all postings of early-release articles on the Web. This service is provided at no charge. Our strength derives from how we evaluate what we publish, and that process can be lengthy
N Engl J Med 348:2029, May 15, 2003 Editorial
|
-
|
Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, Forman S, Ruzyllo W, Maggioni AP, White H, Sadowski Z, Carvalho AC, Rankin JM, Renkin JP, Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, Fridrich V, Mark DB, Knatterud GL
in this circumstance remain to be investigated. The mechanisms of early and late myocardial damage in this trial may be different. The excess early release of a cardiac marker may be a consequence of distal atherothrombotic embolization and microvascular plugging related to PCI. Although the risk of
N Engl J Med 355:2395, December 7, 2006 Original Article
|
-
|
Coombes RC, Hall E, Gibson LJ, Paridaens R, Jassem J, Delozier T, Jones SE, Alvarez I, Bertelli G, Ortmann O, Coates AS, Bajetta E, Dodwell D, Coleman RE, Fallowfield LJ, Mickiewicz E, Andersen J, Lonning PE, Cocconi G, Stewart A, Stuart N, Snowdon CF, Carpentieri M, Massimini G, Bliss JM
-event curves are presented. The groups were compared in terms of the incidence of adverse effects with the use of chi-square tests. Because of the early release of the efficacy results, data on adverse events are provisional; the validation process is ongoing. Here, we emphasize the adverse effects for which
N Engl J Med 350:1081, March 11, 2004 Original Article
|
-
|
Campion EW
http://www.nejm.org). The decision to release an article early is made together with the authors and in accordance with our policy that permits early release when a report may have immediate implications for clinical practice. 1 All the articles released early last year had been peer reviewed and accepted
N Engl J Med 341:2085, December 30, 1999 Editorial
|
-
|
Weber JE, Shofer FS, Larkin GL, Kalaria AS, Hollander JE
evaluation unit, 8 13 when some patients may rapidly resume cocaine use. For that reason, we believed it imperative to document the safety of early release in a prospective, “real-world” setting. The purpose of the current study was to validate prospectively the use of a 9-to-12-hour observation
N Engl J Med 348:510, February 6, 2003 Original Article
|
-
|
Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA
the use of a ramp function. 19 An immediate change was defined as one occurring within three 4-month intervals (i.e., within 1 year) after the early release of the study's findings on the Journal Web site on July 19, 1999, 44 days ahead of its publication in print. 2 To assess delayed effects, we used
N Engl J Med 351:543, August 5, 2004 Original Article
|
|
|
|
|
|
|
|